Cresco Labs Inc. (CRLBF), a cannabis and medical marijuana company, on Wednesday registered a net profit for the fourth-quarter, mainly due to reduced costs and expenses.
For the three-month period, the firm posted a net income of $4.868 million, compared with loss of $180.623 million, recorded for the same period in the previous year.
Cost of sales reduced to $92.091 million from the previous year's $111.876 million.
Total operating expenses plunged to $69.047 million from $231.183 million a year ago.
Revenue was at $188.237 million, lesser than $199.580 million of last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.